1. Home
  2. CVRX vs ACCO Comparison

CVRX vs ACCO Comparison

Compare CVRX & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • ACCO
  • Stock Information
  • Founded
  • CVRX 2000
  • ACCO 1893
  • Country
  • CVRX United States
  • ACCO United States
  • Employees
  • CVRX N/A
  • ACCO N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ACCO Publishing
  • Sector
  • CVRX Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • CVRX 419.8M
  • ACCO 487.6M
  • IPO Year
  • CVRX 2021
  • ACCO N/A
  • Fundamental
  • Price
  • CVRX $13.85
  • ACCO $4.55
  • Analyst Decision
  • CVRX Strong Buy
  • ACCO Buy
  • Analyst Count
  • CVRX 7
  • ACCO 1
  • Target Price
  • CVRX $17.83
  • ACCO $7.50
  • AVG Volume (30 Days)
  • CVRX 219.8K
  • ACCO 758.3K
  • Earning Date
  • CVRX 02-04-2025
  • ACCO 02-20-2025
  • Dividend Yield
  • CVRX N/A
  • ACCO 6.58%
  • EPS Growth
  • CVRX N/A
  • ACCO N/A
  • EPS
  • CVRX N/A
  • ACCO N/A
  • Revenue
  • CVRX $51,292,000.00
  • ACCO $1,666,200,000.00
  • Revenue This Year
  • CVRX $27.21
  • ACCO N/A
  • Revenue Next Year
  • CVRX $25.87
  • ACCO $0.70
  • P/E Ratio
  • CVRX N/A
  • ACCO N/A
  • Revenue Growth
  • CVRX 30.53
  • ACCO N/A
  • 52 Week Low
  • CVRX $6.40
  • ACCO $4.34
  • 52 Week High
  • CVRX $22.50
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 39.53
  • ACCO 32.35
  • Support Level
  • CVRX $14.07
  • ACCO $4.95
  • Resistance Level
  • CVRX $15.42
  • ACCO $5.63
  • Average True Range (ATR)
  • CVRX 0.88
  • ACCO 0.15
  • MACD
  • CVRX -0.23
  • ACCO -0.00
  • Stochastic Oscillator
  • CVRX 13.84
  • ACCO 15.88

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

Share on Social Networks: